Hjem
Camilla Tøndels bilde

Camilla Tøndel

Forsker, post doc/barnenefrolog
  • E-postCamilla.Tondel@uib.no
  • Telefon+47 924 68 262
  • Besøksadresse
    Haukeland Universitetssykehus Laboratoriebygget, 7. etg. Heis øst
  • Postadresse
    Postboks 7804
    5020 Bergen
Vitenskapelig artikkel
  • Thorsteinsdottir, Hjørdis; Salvador, Cathrin Lytomt; Mjøen, Geir; Lie, Anine; Sugulle, Meryam; Tøndel, Camilla; Brun, Atle; Almaas, Runar; Bjerre, Anna Kristina. 2020. Growth Differentiation Factor 15 in Children with Chronic Kidney Disease and after Renal Transplantation. Disease Markers. 1-8.
  • Mohn, Kristin Greve Isdahl; Brokstad, Karl Albert; Islam, Shahinul; Oftung, Fredrik; Tøndel, Camilla; Aarstad, Hans Jørgen; Cox, Rebecca Jane. 2020. Early Induction of Cross-Reactive CD8+ T-Cell Responses in Tonsils After Live-Attenuated Influenza Vaccination in Children. Journal of Infectious Diseases. 1528-1537.
  • Najafian, Behzad; Tøndel, Camilla; Svarstad, Einar; Gubler, Marie-Claire; Oliveira, Joao-Paulo; Mauer, Michael. 2020. Accumulation of Globotriaosylceramide in Podocytes in Fabry Nephropathy Is Associated with Progressive Podocyte Loss. Journal of the American Society of Nephrology. 865-875.
  • Rittig, Søren; Baka-Ostrowska, Malgorzata; Tøndel, Camilla; Johan, Vande Walle; Kjaeer, Birgitta; Passier, Paul; Bosman, Brigitte; Stroosma, Otto; Tannenbaum, Stacey. 2019. The pharmacokinetics, safety, and tolerability of mirabegron in children and adolescents with neurogenic detrusor overactivity or idiopathic overactive bladder and development of a population pharmacokinetic model-based pediatric dose estimation. Journal of Pediatric Urology.
  • Lillås, Bjørn Steinar; Tøndel, Camilla; Gjerde, Anna; Vikse, Bjørn Egil. 2019. Measurement of renal functional response using iohexol clearance—a study of different outpatient procedures. Clinical Kidney Journal. 1-8.
  • Ramaswami, Uma; Bichet, Daniel G; Clarke, Lorne; Dostalova, Gabriela; Fainboim, Alejandro; Fellgiebel, Andreas; Forcelini, Cassiano; An Haak, Kristina; Hopkin, Robert; Mauer, Michael; Najafian, Behzad; Scott, C. Ronald; Shankar, Suma P; Thurberg, Beth; Tøndel, Camilla; Tylki-Szymanska, Anna; Benichou, Bernard; Wijburg, Frits. 2019. Low-dose agalsidase beta treatment in male pediatric patients with Fabry disease: A 5-year randomized controlled trial. Molecular Genetics and Metabolism. 86-94.
  • Spada, Marco; Baron, Ralf; Elliott, Perry M.; Falissard, Bruno; Hilz, Max J.; Monserrat, Lorenzo; Tøndel, Camilla; Tylki-Szymańska, Anna; Wanner, Christoph; Germain, Dominique P. 2018. The effect of enzyme replacement therapy on clinical outcomes in paediatric patients with Fabry disease - A systematic literature review by a European panel of experts. Molecular Genetics and Metabolism. 1-12.
  • Salvador, Cathrin Lytomt; Tøndel, Camilla; Rowe, Alexander D.; Bjerre, Anna Kristina; Brun, Atle; Brackman, Damien; Mørkrid, Lars. 2018. Estimating glomerular filtration rate in children: evaluation of creatinine- and cystatin C-based equations. Pediatric nephrology (Berlin, West). 1-11.
  • Salvador, Cathrin Lytomt; Tøndel, Camilla; Rowe, Alexander D.; Bjerre, Anna Kristina; Brun, Atle; Brackman, Damien; Bolstad, Nils; Mørkrid, Lars. 2017. Renal Function Influences Diagnostic Markers in Serum and Urine: A Study of Guanidinoacetate, Creatine, Human Epididymis Protein 4, and Neutrophil Gelatinase–Associated Lipocalin in Children. The Journal of Applied Laboratory Medicine. 297-308.
  • Eikrem, Øystein Solberg; Skrunes, Rannveig; Tøndel, Camilla; Leh, Sabine Maria; Houge, Gunnar; Svarstad, Einar; Marti, Hans-Peter. 2017. Pathomechanisms of renal Fabry disease. Cell and Tissue Research. 53-62.
  • Skrunes, Rannveig; Tøndel, Camilla; Leh, Sabine Maria; Larsen, Kristin Kampevold; Houge, Gunnar; Davidsen, Einar Skulstad; Hollak, Carla E.M.; Van Kuilenburg, André B.P.; Vaz, Frédéric M.; Svarstad, Einar. 2017. Long-term dose-dependent agalsidase effects on kidney histology in fabry disease. American Society of Nephrology. Clinical Journal. 1470-1479.
  • Tøndel, Camilla; Salvador, Cathrin Lytomt; Hufthammer, Karl Ove; Bolann, Bjørn Johan; Brackman, Damien; Bjerre, Anna Kristina; Svarstad, Einar; Brun, Atle. 2017. Iohexol plasma clearance in children: validation of multiple formulas and single-point sampling times. Pediatric nephrology (Berlin, West). 1-14.
  • Suntjens, Eefje B.; Dreschler, Wouter Albert; Hess-Erga, Jeanette; Skrunes, Rannveig; Wijburg, Frits; Linthorst, Gabor E.; Tøndel, Camilla; Biegstraaten, Marieke. 2017. Hearing loss in children with Fabry disease. Journal of Inherited Metabolic Disease. 725-731.
  • Svarstad, Einar; Leh, Sabine Maria; Skrunes, Rannveig; Larsen, Kristin Kampevold; Eikrem, Øystein Solberg; Tøndel, Camilla. 2017. Bedside stereomicroscopy of Fabry kidney biopsies: An easily available method for diagnosis and assessment of sphingolipid deposits. Nephron. 13-21.
  • Skrunes, Rannveig; Svarstad, Einar; Larsen, Kristin Kampevold; Leh, Sabine Maria; Tøndel, Camilla. 2016. Reaccumulation of globotriaosylceramide in podocytes after agalsidase dose reduction in young Fabry patients. Nephrology, Dialysis and Transplantation. 807-813.
  • Najafian, Behzad; Tøndel, Camilla; Svarstad, Einar; Sokolovkiy, Alexey; Smith, Kelly; Mauer, Michael. 2016. One Year of Enzyme Replacement Therapy Reduces Globotriaosylceramide Inclusions in Podocytes in Male Adult Patients with Fabry Disease. PLOS ONE.
  • Mohn, Kristin Greve Isdahl; Brokstad, Karl Albert; Pathirana, Rishi; Bredholt, Geir; Jul-Larsen, Åsne; Trieu, Mai Chi; Jalloh, Sarah Larteley Lartey; Montemoli, Emanuele; Tøndel, Camilla; Aarstad, Hans Jørgen; Cox, Rebecca Jane. 2016. Live attenuated influenza vaccine in children induces b-cell responses in tonsils. Journal of Infectious Diseases. 722-731.
  • Tøndel, Camilla; Bolann, Bjørn Johan; Salvador, Cathrin Lytomt; Brackman, Damien; Bjerre, Anna Kristina; Svarstad, Einar; Brun, Atle. 2016. Iohexol plasma clearance in children: validation of multiple formulas and two-point sampling times. Pediatric nephrology (Berlin, West). 311-320.
  • Biegstraaten, Marieke; Arngrímsson, R; Barbey, F; Boks, L; Cecchi, Franco; Deegan, PB; Feldt-Rasmussen, Ulla; Geberhiwot, T; Germain, DP; Hendriksz, C; Hughes, DA; Kantola, I; Karabul, N; Lavery, C; Linthorst, GE; Mehta, A; van de Mheen, E; Oliveira, JP; Parini, R; Ramaswami, Uma; Rudnicki, M; Serra, A; Sommer, Claudia; Sunder-Plassmann, G; Svarstad, Einar; Sweeb, A; Terryn, W; Tylki-Szymanska, A; Tøndel, Camilla; Vujkovac, B; Weidemann, Frank; Wijburg, FA; Woolfson, P; Hollak, CE. 2015. Recommendations for initiation and cessation of enzyme replacement therapy in patients with Fabry disease: The European Fabry Working Group consensus document. Orphanet Journal of Rare Diseases. 1-10.
  • Mohn, Kristin Greve Isdahl; Bredholt, Geir; Brokstad, Karl Albert; Pathirana, Rishi; Aarstad, Hans Jørgen; Tøndel, Camilla; Cox, Rebecca Jane. 2015. Longevity of B-cell and T-cell responses after live attenuated influenza vaccination in children. Journal of Infectious Diseases. 1541-1549.
  • Salvador, Cathrin Lytomt; Tøndel, Camilla; Mørkrid, Lars; Bjerre, Anna Kristina; Brun, Atle; Bolann, Bjørn Johan; Brackman, Damien; Bergan, Stein. 2015. Glomerular filtration rate measured by iohexol clearance: A comparison of venous samples and capillary blood spots. Scandinavian Journal of Clinical and Laboratory Investigation. 710-716.
  • Tøndel, Camilla; Kanai, Takahiro; Larsen, Kristin Kampevold; Ito, Shuichi; Politei, Juan Manuel; Warnock, David G; Svarstad, Einar. 2015. Foot process effacement is an early marker of nephropathy in young classic fabry patients without albuminuria. Nephron. 16-21.
  • Tol, Linda van der; Svarstad, Einar; Ortiz, Alberto; Tøndel, Camilla; Oliveira, João Paulo; Vogt, Liffert; Waldek, Stephen; Hughes, Derralynn A.; Lachmann, Robin H.; Terryn, Wim; Hollak, Carla E.M.; Florquin, Sandrine; Weerman, Marius A. van den Bergh; Wanner, Christoph; West, Michael; Biegstraaten, Marieke; Linthorst, Gabor E. 2015. Chronic kidney disease and an uncertain diagnosis of Fabry disease: approach to a correct diagnosis. Molecular Genetics and Metabolism. 242-247.
  • Wijburg, Frits; Benichou, Bernard; Bichet, Daniel G; Lorne, Clarke; Dostalova, Gabriela; Fainboim, Alejandro; Fellgiebel, Andreas; Forcelini, Cassiano; Haack, Kristina An; Hopkin, Robert; Mauer, Michael; Najafian, Behzad; Scott, C. Ronald; Shankar, Suma P; Thurberg, Beth; Tøndel, Camilla; Tylki-Szymanska, Anna; Ramaswami, Uma. 2015. Characterization of early disease status in treatment-naive male paediatric patients with fabry disease enrolled in a randomized clinical trial. PLOS ONE.
  • Tol, Linda van der; Cassiman, David; Houge, Gunnar; Janssen, Mirian C.; Lachmann, Robin; Linthorst, Gabor E.; Ramaswami, Uma; Sommer, Claudia; Tøndel, Camilla; West, Michael; Weidemann, Frank; Wijburg, Frits; Svarstad, Einar; Hollak, Carla E.M.; Biegstraaten, Marieke. 2014. Uncertain diagnosis of fabry disease in patients with neuropathic pain, angiokeratoma or cornea verticillata: consensus on the approach to diagnosis and follow-up. JIMD Reports. 83-90.
  • Mauer, Michael; Glynn, Emily; Svarstad, Einar; Tøndel, Camilla; Gubler, Marie-Claire; West, Michael; Sokolovskiy, Alexey; Whitley, Chester; Najafian, Behzad. 2014. Mosaicism of podocyte involvement is related to podocyte injury in females with Fabry disease. PLOS ONE.
  • Tøndel, Camilla; Bostad, Leif; Larsen, Kristin Kampevold; Hirth, Asle; Vikse, Bjørn Egil; Houge, Gunnar; Svarstad, Einar. 2013. Agalsidase Benefits Renal Histology in Young Patients with Fabry Disease. Journal of the American Society of Nephrology. 137-148.
  • Tøndel, Camilla; Vikse, Bjørn Egil; Bostad, Leif; Svarstad, Einar. 2012. Safety and complications of percutaneous kidney biopsies in 715 children and 8573 adults in Norway 1988-2010. American Society of Nephrology. Clinical Journal. 1591-1597.
  • Linthorst, Gabor E.; Burlina, Allessandro; Cecchi, Franco; Cox, Timothy M.; Fletcher, Janice M.; Feldt-Rasmussen, Ulla; Giugliani, Roberto; Hollak, Carla E.M.; Houge, Gunnar; Hughes, Derralynn A.; Iikka, Kantola; Lachmann, Robin; Lopez, Monica; Ortiz, Alberto; Parini, Rosella; Rivera, Alberto; Rolfs, Arndt; Ramaswami, Uma; Svarstad, Einar; Tøndel, Camilla; Tylki-Szymanska, Anna; Vujkovac, Bojan; Waldek, Stephen; West, Michael; Weidemann, Frank; Mehta, Atul. 2012. Recommendations on Reintroduction of Agalsidase Beta for Patients with Fabry Disease in Europe, Following a Period of Shortage. JIMD Reports.
  • Najafian, Behzad; Svarstad, Einar; Bostad, Leif; Gubler, Marie-Claire; Tøndel, Camilla; Whitley, Chester; Mauer, Michael. 2011. Progressive podocyte injury and globotriaosylceramide (GL-3) accumulation in young patients with Fabry disease. Kidney International. 663-670.
  • Tøndel, Camilla; Ramaswami, Uma; Aakre, Kristin Moberg; Wijburg, Frits; Bouwman, Machtelt; Svarstad, Einar. 2010. Monitoring renal function in children with Fabry disease: comparisons of measured and creatinine-based estimated glomerular filtration rate. Nephrology, Dialysis and Transplantation. 1507-1513.
  • Guest, Julian F; Jenssen, Trond; Houge, Gunnar; Aaseboe, Willy; Tøndel, Camilla; Svarstad, Einar. 2010. Modelling the resource implications of managing adults with Fabry disease in Norway favours home infusion. European Journal of Clinical Investigation. 1104-1112.
  • Aakre, Kristin M.; Tøndel, Camilla; Brun, Atle; Svarstad, Einar. 2009. The MDRD equation may mask decline of glomerular filtration rate in Fabry patients with normal or nearly normal kidney function. Clinical Nephrology. 118-124.
  • Tøndel, Camilla; Ramaswami, Uma; Aakre, Kristin Moberg; Wijburg, Frits; Bouwman, Machtelt; Svarstad, Einar. 2009. Monitoring renal Function in Fabry children: comparisons of measured and creatinine-based estimated Glomerular Filtration Rate. Nephrology, Dialysis and Transplantation. 7 sider.
  • Tøndel, Camilla; Bostad, Leif; Hirth, Asle; Svarstad, Einar. 2008. Renal biopsy findings in children and adolescents with Fabry disease and minimal albuminuria. American Journal of Kidney Diseases. 767-776.
  • Svarstad, Einar; Bostad, Leif; Kaarbøe, Øyvind; Houge, Gunnar; Tøndel, Camilla; Lyngdal, Per Tore; Iversen, Bjarne Magnus. 2005. Focal and segmental glomerular sclerosis (FSGS) in a man and a woman with Fabry's disease. Clinical Nephrology. 394-401.
  • Tøndel, Camilla; Lægreid, Liv Marie; Hirth, Asle; Houge, Gunnar; Månsson, Jan-Eric; Søvik, Oddmund. 2003. [Intravenous Enzyme Substitution Therapy in Children With Fabry's Disease] . Tidsskrift for Den norske legeforening.
  • Juliusson, Petur Benedikt; Tøndel, Camilla; Aanderud, Sylvi; Varhaug, Jan Erik; Følling, Magne; Bjerknes, Robert. 2002. Behandling av Graves sykdom hos barn og unge. Pediatrisk Endokrinologi. 42-46.
Vitenskapelig foredrag
  • Strauss, Philipp; Eikrem, Øystein Solberg; Tøndel, Camilla; Svarstad, Einar; Scherer, Andreas; Leh, Sabine Maria; Flatberg, Arnar; Delaleu, Nicolas; Koch, Even; Beisvag, Vidar; Landolt, Lea Zoe; Marti, Hans-Peter. 2019. Fabry Nephropathy: First mRNA-seq Findings from Kidney Biopsies Before and After Enzyme Replacement Therapy.
  • Mohn, Kristin Greve Isdahl; Cox, Rebecca Jane; Zhou, Fan; Brokstad, Karl Albert; Jul-Larsen, Åsne; Tøndel, Camilla; Aarstad, Hans Jørgen; Sridhar, Saranya. 2015. Cellular immune responses after live attenuated influenza vaccination in children, a clinical trial.
  • Tøndel, Camilla; Svarstad, Einar. 2013. Podocytes: Therapeutic Target in Fabry Disease?
  • Tøndel, Camilla; Bostad, Leif; Svarstad, Einar. 2010. 5 YEARS FOLLOW-UP RENAL BIOPSIES IN PAEDIATRIC AND ADULT FABRY PATIENTS ON ENZYME REPLACEMENT THERAPY.
  • Haugen, Olav H.; Tøndel, Camilla; Svarstad, Einar. 2009. Corneal changes in Fabry's disease.
Leserinnlegg
  • Bertelsen, Anne Kjørsvik; Tøndel, Camilla; Krohn, Jørgen Gitlesen; Bull, Nils; Aarseth, Jan Harald; Houge, Gunnar; Mellgren, Svein Ivar; Vedeler, Christian A. 2013. Small fibre neuropathy in Fabry disease. Journal of Neurology. 917-919.
  • Houge, Gunnar; Tøndel, Camilla; Kaarbøe, Øyvind; Hirth, Asle; Bostad, Leif; Svarstad, Einar. 2011. Fabry or not Fabry – a question of ascertainment. European Journal of Human Genetics. 1111-1112.
Doktorgradsavhandling
  • Salvador, Cathrin Lytomt. 2020. Estimation and measurement of glomerular filtration rate in children.
  • Skrunes, Rannveig. 2017. Hereditary renal disease in the Norwegian population, with a focus on Fabry disease.
  • Tøndel, Camilla. 2013. Markers of nephropathy in young Fabry disease patients; role of kidney biopsies and functional measurement.
Intervju
  • Tøndel, Camilla. 2015. Kreft hos barn og betydning av klinisk utprøving hos barn.
  • Tøndel, Camilla. 2015. Har testet medisiner på 400 barn.
  • Gunnes, Maria Winther; Tøndel, Camilla. 2014. Kampen mot kreft.
  • Tøndel, Camilla. 2013. Forskning på medisiner til barn, Ekko .
Programdeltagelse
  • Tøndel, Camilla. 2015. Liv og død-serien; Legemiddelutprøving hos barn.
Sammendrag/abstract
  • Najafian, Behzad; Whitley, Chester; Thurberg, Beth; Svarstad, Einar; Tøndel, Camilla; Gubler, Marie-Claire; West, Michael; Mauer, Michael. 2013. Renal structural-functional relationship (SFR) studies suggest that podocyte GL-3 accumulation predicts urine protein creatinine ratio in Fabry disease (FD) nephropathy (FDN). Molecular Genetics and Metabolism. S68-S69.
  • Salvador, Cathrin Lytomt; Tøndel, Camilla; Mørkrid, Lars; Bjerre, Anna Kristina; Bolann, Bjørn Johan; Brun, Atle; Brackman, Damien; Bergan, Stein. 2013. GLOMERULAR FILTRATION RATE (GFR) MEASURED BY IOHEXOL CLEARANCE IN CHILDREN; A COMPARISON BETWEEN VENOUS SAMPLES AND DRIED BLOOD SPOTS. Pediatric nephrology (Berlin, West). 1653-1654.
  • Wijburg, Frits; Benichou, Bernard; Bichet, Daniel G; Dostalova, Gabriela; Clarke, Lorne; Fainboim, Alejandro; Fellgiebel, Andreas; Forcelini, Cassiano; Haack, Kristina An; Hopkin, Robert; Scott, C Ronald; Shankar, Suma; Tylki-Szymanska, Anna; Tøndel, Camilla; Ramaswami, Uma. 2013. A randomized, multicenter, multinational, phase 3B, open-label, parallel-group study of agalsidase beta in treatment-naive male pediatric patients with Fabry disease without severe symptoms: Baseline demographics and clinical data. Molecular Genetics and Metabolism. S99-S99.
  • Najafian, Behzad; Glynn, Emily; Svarstad, Einar; Tøndel, Camilla; Whitley, Chester; Mauer, Michael. 2012. Mosaicism of Podocyte Involvement in Untreated Females with Fabry Disease. Molecular Genetics and Metabolism. S47-S48.
  • Tøndel, Camilla; Bostad, Leif; Svarstad, Einar. 2010. RENAL FOLLOW-UP BIOPSIES IN YOUNG MALE FABRY PATIENTS ON ENZYME REPLACEMENT THERAPY. Clinical Therapeutics. S105-S107.
  • Tøndel, Camilla; Ramaswami, Uma; Aakre, Kristin Moberg; Wijburg, Frits; Bouwman, Machtelt; Svarstad, Einar. 2009. Monitoring renal Function in Fabry children; estimated or measured glomerular Filtration rate? Molecular Genetics and Metabolism. 74-75.
  • Tøndel, Camilla; Bertelsen, Anne Kjørsvik; Bostad, Leif; Lind, Ola; Svarstad, Einar. 2009. Fabry Disease: Unusual Symptoms in two Boys Treated with Lamotrigine and Fabrazyme, Respectively. Clinical Therapeutics. S43-S43.
  • Tøndel, Camilla; Bostad, Leif; Lægreid, Liv Marie; Houge, Gunnar; Svarstad, Einar. 2008. Prominence of glomerular and vascular changes in renal biopsies in children and adolescents with Fabry disease and microalbuminuria. Clinical Therapeutics. S42-S42.
Poster
  • Linhart, Aleš; Dostalova, Gabriela; Nicholls, Kathleen; West, Michael; Tøndel, Camilla; Jovanovic, Ana; Giraldo, Pilar; Vujkovac, Bojan; Hiwot, Tarekegn; Almon, Einat; Alon, Sari; Szlaifer, Mali; Chertkoff, Raul; Hughes, Derralynn A. 2020. Switching from agalsidase alfa to pegunigalsidase alfa for treating Fabry disease: One year of treatment data from BRIDGE, a phase III open label study .
  • Linhart, Aleš; Nicholls, Kathy; West, Michael; Tøndel, Camilla; Jovanovic, Ana; Giraldo, Pilar; Vujkovac, Bojan; Tarekegn, Hiwot; Almon, Einat; Alon, Sari; Amit-Cohen, Bat-chen; Szlaifer, Mali; Chertkoff, Raul; Hughes, Derralynn A. 2019. Prelimenary Results of the Fabry Disease Phase III Open Label Study of Switching from Agalsidase Alfa to Pegunigalsidase Alfa.
  • Linhart, Aleš; Nicholls, Kathy; West, Michael; Tøndel, Camilla; Jovanovic, Ana; Giraldo, Pilar; Langeveld, Mirjam; Vujkovac, Bojan; Almon, Einat; Alon, Sari; Amit-Cohen, Bat-chen; Szlaifer, Mali; Chertkoff, Raul; Hughes, Derralynn A. 2019. Pegunigalsidase alfa for the treatment of Fabry disease - Phase III open label, switch over study from agalsidase alfa - Preliminary results.
  • Holida, Myrl; Bernat, John; Longo, Nicola; Goker-Alpan, Ozlem; Wallace, Eric; Schiffmann, Raphael; Deegan, Patrick; Khan, Nedd; Tøndel, Camilla; Eyskens, Francois; Hughes, Derralynn A.; West, Michael; Giraldo, Pilar; Ezgu, Fatih; Almon, Einat; Alon, Sari; Amit-Cohen, Bat-chen; Szlaifer, Mali; Chertkoff, Raul; Wilcox, William. 2019. Once every 4 weeks 2 mg/kg of pegunigalsidase alfa for treating Fabry disease- preliminary result of a phase 3 study.
  • Holida, Myrl; Bernat, John; Longo, Nicola; Goker-Alpan, Ozlem; Wallace, Eric; Schiffmann, Raphael; Deegan, Patrick; Khan, Nedd; Tøndel, Camilla; Eyskens, Francois; Hughes, Derralynn A.; West, Michael; Giraldo, Pilar; Ezgu, Fatih; Feldt-Rasmussen, Ulla; Pisani, Antonio; Dau-Ming, Niu; Almon, Einat; Alon, Sari; Amit-Cohen, Bat-chen; Szlaifer, Mali; Chertkoff, Raul; Wilcox, William. 2019. New Regimen of Once Every 4 Weeks 2 mg/kg of Pedunigalsidase Alfa for Treating Fabry Disease - Prelimenary Results of a Phase 3 Study.
  • Lillås, Bjørn Steinar; Tøndel, Camilla; Gjerde, Anna; Vikse, Bjørn Egil. 2019. Measurement of renal functional response using iohexol clearance.
  • Svarstad, Einar; Skrunes, Rannveig; Davidsen, Einar Skulstad; Leh, Sabine Maria; Larsen, Kristin Kampevold; Reinholt, Finn P.; Strøm, Erik Heyerdahl; Tøndel, Camilla. 2019. Clinical Consequences of Paired Cardiac and Kidney Biopsies in a Treatment Naive Female Fabry Patient with a Classical Mutation and Minor Clnical Symptoms.
  • Warnock, David G; Wallace, Eric; Schiffman, Raphael; Holida, Myrl; Bernat, John; Langeveld, Mirjam; Goker-Alpan, Ozlem; Hopkin, Robert; Giraldo, Pilar; Nedd, Khan; Vujkovac, Bojan; Wilcox, William; Linhart, Aleš; Tøndel, Camilla; Barshop, Bruce; Karaa, Amel; Molnar, Maria Judith; Deegan, Patrick; Vockley, Gerard; Rhead, William; Kimonis, Virginia; Ezgu, Fatih; Lau, Heather; Whitley, Chester; Antongiovanni, Norberto Ricardo; Waldek, Stephen; Almon, Einat; Alon, Sari; Amit-Cohen, Bat-chen; Szlaifer, Mali; Chertkoff, Raul; Longo, Nicola. 2019. Analysis of the baseline characteristics of Fabry disease patients screened for the pegunigalsidase alfa Phase III BALANCE study .
  • Najafian, Behzad; Tøndel, Camilla; Svarstad, Einar; Oliveira, JP; Mauer, Michael. 2019. Accumulation of Globotriaosylceramide in Podocytes (PC) in Fabry Nephropathy Is Associated with Progressive PC Loss.
  • Eide, Thea Tislevoll; Brun, Atle; Brackman, Damien; Bolann, Bjørn Johan; Svarstad, Einar; Tøndel, Camilla. 2018. SINGLE INTRAVENOUS ACCESS FOR MEASUREMENT OF GLOMERULAR FILTRATION RATE IN CHILDREN AFTER MARKER INJECTION.
  • Najafian, Behzad; Tøndel, Camilla; Svarstad, Einar; Mauer, Michael. 2018. Podocyte structural parameters predict glomerular filtration rate (GFR) loss in male patients with classic Fabry disease.
  • Wanner, Christoph; Elliot, PM; Formin, V; Germain, DP; Hilz, MJ; Mignani, Renzo; Nowak, Albina; Oliveira, JP; Ortiz, Alberto; Spada, M; Tøndel, Camilla. 2018. KIDNEY-SPECIFIC THERAPEUTIC GOALS FOR FABRY DISEASE BASED ON EUROPEAN EXPERT CONSENSUS RECOMMENDATIONS AND SYSTEMATIC REVIEW OF PUBLISHED EVIDENCE.
  • Tøndel, Camilla; Salvador, Cathrin Lytomt; Hufthammer, Karl Ove; Bolann, Bjørn Johan; Brackman, Damien; Bjerre, Anna Kristina; Svarstad, Einar; Brun, Atle. 2018. IOHEXOL CLEARANCE IN CHILDREN WITH LOW GFR: COMPARISON OF 24 HOURS SINGLE-POINT GFR AND MULTIPLE-POINT GFR.
  • Eikrem, Øystein Solberg; Strauss, Philipp; Sekulic, Miroslav; Tøndel, Camilla; Flatberg, Arnar; Skrunes, Rannveig; Landolt, Lea Zoe; Babickova, Janka; Leh, Sabine Maria; Scherer, Andreas; Svarstad, Einar; Marti, Hans-Peter. 2018. Fabry nephropathy: Transcriptome sequencing of microdissected renal compartments from archival kidney biopsies at baseline, and after 5 & 10 years of enzyme replacement therapy.
  • Tøndel, Camilla; Salvador, Cathrin Lytomt; Hufthammer, Karl Ove; Bolann, Bjørn Johan; Brackman, Damien; Bjerre, Anna Kristina; Svarstad, Einar; Brun, Atle. 2017. Single-point iohexol plasma clearance in children: validation of multiple formulas and sampling times.
  • Svarstad, Einar; Skrunes, Rannveig; Leh, Sabine Maria; Larsen, Kristin Kampevold; Tøndel, Camilla. 2017. Simplified Clinical Pre-histologic Scoring Method of Kidney Biopsies in Fabry Disease.
  • Najafian, Behzad; Tøndel, Camilla; Svarstad, Einar; Mauer, Michael. 2017. Podocyte globotriaosylceramide (GL-3) content strongly impacts age-dependent podocyte loss in ERT-naïve male Fabry patients.
  • Ramaswami, Uma; Wijburg, Frits; Bichet, Daniel G; Clarke, Lorne; Dostalova, Gabriela; Fainboim, Alejandro; Fellgiebel, Andreas; Forcelini, Cassiano; An Haak, Kristina; Hopkin, Robert; Mauer, Michael; Najafian, Behzad; Scott, Cynthia; Shankar, Suma; Thurberg, Beth; Tøndel, Camilla; Tylki-Szymanska, Anna; Benichou, Bernard. 2017. A randomized, phase 3B, open-label, parallel-group study of agalsidase beta in treatment-naive male pediatric patients with Fabry disease without severe symptoms (FIELD study): GL-3 clearance from superficial skin capillary endothelium.
  • Ramaswami, Uma; Wijburg, Frits; Bichet, Daniel G; Clarke, Lorne; Dostolova, Gabriela; Fainboim, Alejandro; Fellgiebel, Andreas; Forcelini, Cassiano; An Haak, Kristina; Hopkin, Robert; Mauer, Michael; Najafian, Behzad; Scott, Cynthia; Shankar, Suma; Thurberg, Beth; Tøndel, Camilla; Tylki-Szymanska, Anna; Benichou, Bernard. 2017. A randomized, phase 3B, open-label, parallel-group study of agalsidase beta in treatment-naive male pediatric patients with Fabry disease without severe symptoms (FIELD study): GL-3 clearance from kidney cells.
  • Najafian, Behzad; Tøndel, Camilla; Svarstad, Einar; Mauer, Michael. 2016. Podocyte Hypertrophy and Globotriaosylceramide (GL-3) Accumulation Are Strong Predictors of Podocyte Loss in Enzyme Replacement Therapy Naïve Male Patients with Fabry Disease.
  • Salvador, Cathrin Lytomt; Rowe, Alexander D.; Bjerre, Anna Kristina; Tøndel, Camilla; Brun, Atle; Brackman, Damien; Mørkrid, Lars. 2016. Glomerular filtration rate (GFR) strongly influences guanidinoacetic acid (GAA) in plasma and urine.
  • Thorsteinsdottir, Hjørdis; Salvador, Cathrin Lytomt; Tøndel, Camilla; Mjøen, Geir; Brun, Atle; Brackman, Damien; Bjerre, Anna Kristina. 2016. GDF-15 in plasma and urine as a marker of kidney function in children .
  • Chang, Fu-Pang; Mauer, Michael; Sokolovskiy, Alexey; Tøndel, Camilla; Svarstad, Einar; Najafian, Behzad. 2016. Differential response of glomerular parietal epithelial cells and podocytes to enzyme replacement therapy in Fabry nephropathy.
  • Najafian, Behzad; Tøndel, Camilla; Svarstad, Einar; West, Michael; Mauer, Michael. 2015. Podocyte Globotriaosylceramide (GL3) Accumulation in Fabry Disease Is Influenced by Age and Genotype .
  • Skrunes, Rannveig; Tøndel, Camilla; Larsen, Kristin Kampevold; Leh, Sabine Maria; Svarstad, Einar. 2015. LONG-TERM ENZYME REPLACEMENT THERAPY (ERT) BENEFITS THE GLOMERULI MORE THAN THE VASCULATURE IN YOUNGER FABRY NEPHROPATHY .
  • Skrunes, Rannveig; Larsen, Kristin Kampevold; Leh, Sabine Maria; Strøm, Erik Heyerdahl; Jenssen, Trond Geir; Tøndel, Camilla; Svarstad, Einar. 2015. FABRY DISEASE DIAGNOSED IN LIVING DONOR KIDNEY TRANSPLANT BIOPSY.
  • Skrunes, Rannveig; Svarstad, Einar; Larsen, Kristin Kampevold; Leh, Sabine Maria; Tøndel, Camilla. 2015. DIFFERENTIAL KIDNEY EFFECTS OF HIGH AND LOW ENZYME DOSE IN MALE SIBLINGS TREATED FOR 13 YEARS .
  • Tøndel, Camilla; Larsen, Kristin Kampevold; Skrunes, Rannveig; Leh, Sabine Maria; Svarstad, Einar. 2014. Renal Biopsies after 6-11 Years of Enzyme Replacement Therapy in 9 Young Classic Fabry Disease Patients.
  • Tøndel, Camilla; Kanai, Takahiro; Larsen, Kristin Kampevold; Ito, Shuichi; Politei, Juan Manuel; Svarstad, Einar; Warnock, David G. 2014. Five Children with Fabry Disease and Significant Tissue Damage in Renal Biopsies Despite Normal Clinical Renal Parameters.
  • Skrunes, Rannveig; Larsen, Kristin Kampevold; Svarstad, Einar; Tøndel, Camilla. 2014. Fabry nephropathy (FN) outcome and the impact of diagnostic kidney biopsies after 10 years enzyme replacement therapy (ERT).
  • Najafian, Behzad; Mauer, Michael; Svarstad, Einar; Tøndel, Camilla. 2014. Enzyme Replacement Therapy (ERT) in Fabry Disease (FD) Reduces Podocyte (PC) Globotriaosylceramide (GL3) Content within a Year (yr).
  • Tol, Linda van der; Vogt, L; Florquin, S; Biegstraaten, Marieke; Weerman, MA vd B; Hollak, Carla E.M.; Hughes, Derralynn A.; Lachmann, RH; Oliveira, João Paulo; Ortiz, Alberto; Svarstad, Einar; Terryn, W; Tøndel, Camilla; Waldek, Stephen; Wanner, Christoph; West, Michael; Linthorst, Gabor E. 2014. Consensus recommendation on Fabry disease diagnosis in adult patients with kidney disease.
  • Tøndel, Camilla; Bolann, Bjørn Johan; Salvador, Cathrin Lytomt; Brackman, Damien; Svarstad, Einar; Bjerre, Anna Kristina; Brun, Atle. 2013. Glomerular filtration rate (GFR) measured by iohexolclearance in children; how many sample points are necessary?
  • Salvador, Cathrin Lytomt; Tøndel, Camilla; Mørkrid, Lars; Bjerre, Anna Kristina; Bolann, Bjørn Johan; Brun, Atle; Brackman, Damien; Bergan, Stein. 2013. Glomerular Filtration Rate (GFR) measured by Iohexol Clearance in Children; a comparison between venous samples and dried spots.
  • Tøndel, Camilla; Svarstad, Einar; Bostad, Leif. 2009. Renal follow-up biopsies in young male Fabry patients on enzyme replacement therapy.
  • Tøndel, Camilla; Vikse, Bjørn Egil; Iversen, Bjarne Magnus; Bostad, Leif; Svarstad, Einar. 2008. Renal biopsies in children in Norway 1988-2005: clinical variables, complications and prognosis.
  • Tøndel, Camilla; Aakre, Kristin M.; Brun, Atle; Svarstad, Einar. 2008. Formula GFR overestimates Renal Function in Children and Adult Males with Fabry Disease and Stage 1-2 CKD.
  • Tøndel, Camilla; Bertelsen, AK; Bostad, Leif; Lind, Ola; Schjøtt, Jan. 2008. Fabry disease: Unusual symptoms in two male children treated with lamotrigine and fabrazyme, respectively.
Errata
  • Tøndel, Camilla; Bolann, Bjørn Johan; Salvador, Cathrin Lytomt; Brackman, Damien; Bjerre, Anna Kristina; Svarstad, Einar; Brun, Atle. 2016. Erratum to: Iohexol plasma clearance in children: validation of multiple formulas and two-point sampling times (Pediatric Nephrology, (2017), 32, 2, (311-320), 10.1007/s00467-016-3436-z). Pediatric nephrology (Berlin, West). 375-376.
Vitenskapelig oversiktsartikkel/review
  • Wanner, Christoph; Arad, Michael; Baron, Ralf; Burlina, Allessandro; Elliott, Perry M.; Feldt-Rasmussen, Ulla; Fomin, Victor V.; Germain, Dominique P.; Hughes, Derralynn A.; Jovanovic, Ana; Kantola, Ilkka; Linhart, Aleš; Mignani, Renzo; Monserrat, Lorenzo; Namdar, Mehdi; Nowak, Albina; Oliveira, João Paulo; Ortiz, Alberto; Pieroni, Maurizio; Spada, Marco; Tylki-Szymańska, Anna; Tøndel, Camilla; Viana-Baptista, Miguel; Weidemann, Frank; Hilz, Max J. 2018. European expert consensus statement on therapeutic goals in Fabry disease. 189-203.

Se fullstendig oversikt over publikasjoner i CRIStin.

Forskergrupper